Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)

219
Delayed Quote. Delayed CHI-X - 01/27 03:15:41 am
255.4 CHF   +0.12%
01/22DJROCHE : Full-Year Earnings Seen Rising -- Earnings Preview
01/22DJROCHE : Profit May Rise -- Earnings Preview
01/22DJRoche Holding AG Full-year 2014 -- Forecast
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ROCHE HOLDING LTD.
01/22DJROCHE : Full-Year Earnings Seen Rising -- Earnings Preview
01/22DJROCHE : Profit May Rise -- Earnings Preview
01/22DJRoche Holding AG Full-year 2014 -- Forecast
01/17DJInvesting for the Long Term
01/16DJRoche to Acquire France-Based Biotech Company
01/16DJRoche to Acquire France-Based Biotech Company
01/15 ROCHE : A First in North America: CDL Laboratories acquire the latest technology..
01/15 From watchmakers to ski resorts, Swiss firms hammered by franc surge
01/15 Roche says spread of currencies mitigates impact of franc surge
01/14DJNew Medical School Planned for New Jersey
01/13DJWorkers Get Help Climbing the Corporate Ladder
01/13 Roche seals licensing deal for antibiotic-boosting drug to battle superbugs
01/12DJU.S. Stock Futures Increase After 2 Losing Weeks
01/12 Roche in $1 billion-plus Foundation Medicine deal to boost cancer efforts
01/12DJRoche Holding to Pay $1.03 Billion for Diagnostics-Firm Stake
01/12DJRoche To Buy Test-Firm Stake
2014 ROCHE : FDA Approves Gazyva® (Obinutuzumab) Supplemental Biologics License Appli..
2014 ROCHE : says agrees to buy Bina Technologies for undisclosed price
2014DJROCHE : Stops Alzheimer Drug Trial; Shows Mixed Results in Breast Cancer Study
2014 ROCHE : Genentech : Provides Update on Phase III MARIANNE Study in People with P..
2014 Roche to pay up to $489 million for next-generation antibody developer
2014DJFrance Told To Do More for Foreign Investors
2014 ROCHE : Genentech : Submits New Drug Application to FDA for Investigational Cobi..
2014DJNOVARTIS : Afinitor Fails to Make a Significant Treatment Difference
2014DJROCHE : Correction to Roche story
2014DJRoche Names New Genentech R&D Chief
2014DJRoche Names New Genentech R&D Chief
2014 Roche says head of Genentech research unit to retire
2014 Merck to take on superbugs with Cubist Pharma buy
2014 Merck to take on superbugs with Cubist Pharma buy
2014 ROCHE : Genentech : to Present Clinical Data from Six Different Medicines at Ame..
2014 Novartis and Roche suffer setback in Italian collusion case
2014DJROCHE : Acquires Ariosa Diagnostics
2014DJBristol-Myers, Five Prime to Collaborate on Immunotherapy
2014 U.S. court denies Ranbaxy's bid to block launch of rival generics
2014 Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies
2014 Pfizer dampens Astra bid hopes with German Merck cancer deal
2014DJROCHE : Gets U.S. Approval for Avastin Treatment of Ovarian Cancer
2014 ROCHE : FDA Approves Genentech’s Avastin (bevacizumab) Plus Chemotherapy t..
2014 Weak Merck sales overshadow third quarter cost cuts
2014 Roche to spend $3.2 billion on towering Basel base
2014DJRoche to Spend CHF3 Billion in Research Center, Basel Headquarters
2014 ROCHE : Pharmacyclics Enters Into Agreement with Roche to Evaluate IMBRUVICA® an..
2014 New breast cancer drugs boost sales at Roche
2014 ROCHE : FDA Approves Esbriet® (pirfenidone) for the Treatment of Idiopathic Pulm..
2014DJRoche Holding 3Q 2014 -- Forecast
2014 ROCHE : FDA Grants Priority Review for Genentech’s Lucentis in Diabetic Re..
2014 NOVARTIS : Shareholder group critical as Roche and Novartis chiefs top Swiss pay..
2014 ROCHE : Genentech :’s Investigational Combination of Cobimetinib Plus Zelb..
2014 ROCHE : Genentech :’s Perjeta Regimen Extended the Lives of People With an..
2014 Adaptimmune raises $104 million to develop immune-system cancer drugs
2014 For Roche CEO, celebrating failure is key to success
2014 Roche's $8 billion InterMune buy not a signal for more big deals
2014 Cost a focus as GSK takes lead in new wave of biotech lung drugs
2014 Roche rules out mega deals, open to smaller ones - paper
2014 Ex-Genentech boss Levinson resigns from Roche's board
2014 Google's Calico, AbbVie forge deal against diseases of aging
2014 InterMune drug may offer big upside to Roche if aimed at liver
2014DJMARKET SNAPSHOT : S&P 500 Jumps To Record Close Just Below 2,000
2014 S&P 500 sets record high but fails to hold 2,000 mark
2014DJMARKET SNAPSHOT : S&P 500 Jumps To Record Close Just Below 2,000
2014DJMARKET SNAPSHOT : U.S. Stocks Rise; S&P 500 Tries To Close Above 2,000
2014 ROCHE : Harwood Feffer LLP : Announces Investigation of Intermune, Inc.
2014DJMARKET SNAPSHOT : U.S. Stocks: S&P 500 Leaps Over 2,000 For Intraday Record
2014DJMARKET SNAPSHOT : S&P 500 Jumps Above 2,000 For Intraday Record
2014DJMARKET SNAPSHOT : U.S. Stocks Gain; S&P 500 Nears 2,000
2014DJMARKET SNAPSHOT : U.S. Stocks: Futures Higher As Draghi Lifts Europe
2014DJMARKET SNAPSHOT : U.S. Stocks: Futures Higher As Draghi Lifts Europe
2014DJMARKET SNAPSHOT : U.S. Stocks: Futures Higher As Draghi Lifts Europe
2014 Roche to buy U.S. biotech firm InterMune for $8.3 billion
2014 Roche to buy U.S. biotech firm InterMune for $8.3 billion
2014 ROCHE : and InterMune Reach Definitive Merger Agreement
2014DJZurich Stocks Mostly Higher; Swisscom Down -- Market Talk
2014DJEUROPE MARKETS : United Internet, Roche Climb In European Trading
2014DJEUROPE MARKETS : United Internet, Roche Climb In European Trading
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF